Skip to main content
SpringerLink
Log in

Use of 5-HT Receptor Agonists and Antagonists for the Characterization of Their Respective Receptor Sites

  • Protocol
Drugs as Tools in Neurotransmitter Research

Part of the book series: Neuromethods ((NM,volume 12))

Abstract

Serotonin (5-hydroxytryptamine, 5-HT), was discovered as a serum factor that exerts tonic effects on blood vessels; its chemical structure was elucidated in 1948. The compound gained wide interest among pharmacologists, and in a short time a great number of in vitro and in vivo pharmacological tests had been developed, and a variety of drugs interacting with the actions of serotonin were rapidly discovered. In 1966, Gyermek, in a review on “Drugs which antagonize 5-hydroxytryptamine and related indolealkylamines,” compiled a table with 384 compounds with serotonin antagonistic properties; these compounds belonged to more than 18 different chemical and pharmacological classes. In addition, an impressive list was reported that consisted of 26 different tests for measuring serotonergic effects on isolated organs and 33 tests related to the action of serotonin in vivo, plus a number of indirect effects. At that time, the author wondered whether the vast interest paid to serotonin was fully deserved. He stated, “It turned out that besides the potent pharmacological actions of exogenous serotonin, the endogenous amine in mammals does not play many well-defined physiologic or pathologic roles.” Existing drugs were found to be nonselective, and it was hoped that “specific antagonists” would be developed for analyzing the effects of indolealkylamines in various organisms (Gyermek, 1966).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aghajanian G K. (1981) The Modulatory Role of Serotonin of Multiple Receptors in Brain, in Serotonin Neurotransmission and Behavior (Jacobs B L. and Gelperin A, eds.) MIT Press, Cambridge, Massachusetts

    Google Scholar 

  • Awouters F, Leysen J. E., De Clerck F., and Van Nueten J. M. (1982) General Pharmacological Profile of Ketanserin (R 41 468), A Selective 5-HT2 Receptor Antagonist, in 5-Hydroxytryptamine in Peripheral Reactions (De Clerck F. and Vanhoutte P. M., eds.) Raven, New York.

    Google Scholar 

  • Baron J. C, Samson Y., Comar D., Crouzel C, Deniker P., and Agid, Y. (1985) Etude in vivo des récepteurs sérotoninergiques centraux chez l’homme par tomographie a positons. Rev. Neurol. (Paris) 141, 537–545

    PubMed  CAS  Google Scholar 

  • Beart P. M, McDonald D., Cincotta M., de Vries D. J., and Gundlach A L. (1986) Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex. Gen. Pharmacol 17, 57–62.

    Article  PubMed  CAS  Google Scholar 

  • Bennett, Jr, J. P and Snyder S. H. (1976) Serotonin and lysergic acid diethylamide binding in rat brain membranes: Relationship to postsynaptic serotonin receptors. Mol Pharmacol 12, 373–389.

    PubMed  CAS  Google Scholar 

  • Berridge M J (1984) Inositol trisphosphate and diacylglycerol as second messengers. Biochem. J. 220, 345–360.

    PubMed  CAS  Google Scholar 

  • Blackshear M A, Friedman R L., and Sanders-Bush E. (1983) Acute and chronic effects of serotonin (5-HT) antagonists on serotonin binding sites. Naunyn Schmiedebergs Arch Pharmacol 324, 125–129.

    Article  PubMed  CAS  Google Scholar 

  • Brown E., Kendall D A., and Nahorski S. R. (1984) Inositol phospholipid hydrolysis in rat cerebral cortical slices. I. Receptor characterization. J. Neurochem. 42, 1379–1387.

    Article  PubMed  CAS  Google Scholar 

  • Cohen M. L and Wittenauer L. A (1985) Further evidence that the serotonin receptor in the rat stomach fundus is not 5-HT1A or 5-HT1B. Life Sci. 38, 1–5.

    Article  Google Scholar 

  • Cohen M. L, Kurz K D, Mason N. R, Fuller R W, Marzoni G. P., and Gabrecht W L. (1985a) Pharmacological activity of the isomers of LY-53857, potent and selective 5-HT2 receptor antagonists. J. Pharmacol. Exp. Ther 235, 319–323

    PubMed  CAS  Google Scholar 

  • Cohen M. L, Schenck K W, Colbert W., and Wittenauer L (1985b) Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle J Pharmacol Exp. Ther 232, 770–774.

    PubMed  CAS  Google Scholar 

  • Cohen R. A. and Vanhoutte P. M. (1985) Platelets, Serotonin and Endothlial Cells, in Serotonin and the Cardiovascular System (Vanhoutte P M, ed.) Raven, New York

    Google Scholar 

  • Colpaert F. C, Niemegeers C J. E., and Janssen P. A. J. (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): In vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist. J. Pharmacol. Exp Ther. 221, 206–214.

    PubMed  CAS  Google Scholar 

  • Conn P J. and Sanders-Bush E (1985) Serotonin-stimulated phosphoino-sitide turnover Mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. J. Pharmacol Exp. Ther 234, 195–203

    PubMed  CAS  Google Scholar 

  • Cortes R., Palacios J. M., and Pazos A. (1984) Visualization of multiple serotonin receptors in the rat brain by autoradiography. Br J Pharmacol. 82, 202P

    Google Scholar 

  • Curro F. A, Greenberg S., Verbeuren T J., and Vanhoutte P. M. (1978) Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins J. Pharmacol. Exp. Ther 207, 936–949.

    PubMed  CAS  Google Scholar 

  • Dahlstrom A. and Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system I. Demonstration of monoamines in cell bodies of brain neurons. Acta Physiol. Scand 62(suppl. 232), 1–55.

    Google Scholar 

  • de Chaffoy de Courcelles D, Roevens P., and Van Belle H. (1984) Stimulation by serotonin of 40 kDa and 20 kDa protein phosphorylation in human platelets. FEBS Lett. 171, 289–292

    Article  Google Scholar 

  • de Chaffoy de Courcelles D., Leysen J. E., De Clerck F., Van Belle H., and Janssen P A J. (1985) Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites J. Biol. Chem. 260, 7603–7608.

    Google Scholar 

  • De Clerck F., Xhonneux B., Leysen J., and Janssen P. A. J (1984a) The involvement of 5-HT2 receptor sites in the activation of cat platelets. Thromb. Res. 33, 305–321.

    Article  PubMed  Google Scholar 

  • De Clerck F., Xhonneux B., Leysen J. E, and Janssen P A J. (1984b) Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochem. Pharmacol. 33, 2807–2811.

    Article  PubMed  Google Scholar 

  • Dompert W. U., Glaser T., and Traber J. (1985) [3H] TVx Q 7821 Identification of 5-HT1 binding sites as target for a novel putative anxiolytic. Naunyn Schmiedebergs Arch. Pharmacol. 328, 467–470.

    Article  PubMed  CAS  Google Scholar 

  • Emerit M B., Gozlan H., Hall M. D, Hamon M., and Marquet A. (1985a) Irreversible blockade of central 5-HT binding sites by 8-methoxy-2′-chloro-PAT. Biochem. Pharmacol 34, 883–892

    Article  PubMed  CAS  Google Scholar 

  • Emerit M. B., Gozlan H, Hall M. D, Marquet A., and Hamon M. (1985b) Photoaffinity labelling of 5-HT binding sites. Neurosci Lett, suppl. 22, S552.

    Google Scholar 

  • Engel G., Gothert M., Muller-Schweinitzer E, Schlicker E., Sistonen L, and Stadler P. A (1983) Evidence for common pharmacological properties of [3H] 5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn Schmiedebergs Arch. Pharmacol 324, 116–124

    Article  PubMed  CAS  Google Scholar 

  • Engel G., Hoyer D., Kalkman H O., and Wick M. B (1984a) Identification of 5-HT2-receptors on longitudinal muscle of the guinea pig ileum. J Recept Res 4, 113–126.

    PubMed  CAS  Google Scholar 

  • Engel G., Muller-Schweinitzer E., and Palacios J M. (1984b) 2-[125Iodo]LSD, a new ligand for the characterization and localisation of 5-HT2 receptors. Naunyn Schmiedebergs Arch. Pharmacol 325, 328–336.

    Article  PubMed  CAS  Google Scholar 

  • Fozard J. R. (1984) MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 326, 36–44

    Article  PubMed  CAS  Google Scholar 

  • Friedman R., Barrett R J., and Sanders-Bush E. (1984) Discriminative stimulus properties of quipazine Mediation by serotonm2 binding sites. J. Pharmacol Exp Ther. 228, 628–635.

    PubMed  CAS  Google Scholar 

  • Gaddum J. H. and Picarelli Z. P (1957) Two kinds of tryptamine receptors. Br J. Pharmacol 12, 323–328.

    CAS  Google Scholar 

  • Geaney D. P., Schachter M., Elliott J. M., and Graham-Smith D. G (1984) Characterisation of [3H] lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes Eur. J. Pharmacol. 97, 87–94

    Article  PubMed  CAS  Google Scholar 

  • Glaser T. and Traber J. (1985) Binding of the putative anxiolytic TVx Q-7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites. Naunyn Schmiedebergs Arch. Pharmacol. 329, 211–215.

    Article  PubMed  CAS  Google Scholar 

  • Glaser T., Rath M, Traber J., Zilles K, and Schleicher A. (1985) Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVx Q 7821. Brain Res. 358, 129–136.

    Article  PubMed  CAS  Google Scholar 

  • Glennon R. A, Young R., and Rosecrans J. A. (1983) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur. J Pharmacol 91, 197–206.

    Article  Google Scholar 

  • Glennon R. A., Titeler M., and McKenney J. D. (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35, 2505–2511.

    Article  PubMed  CAS  Google Scholar 

  • Goodwin G M. and Green A. R. (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br. J. Pharmacol. 84, 743–753.

    PubMed  CAS  Google Scholar 

  • Gozlan H., El Meshkawy S., Pichat L., Glowinski J., and Hamon M. (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305, 140–142.

    Article  PubMed  CAS  Google Scholar 

  • Green A. R, ed. (1985) Neuropharmacology of Serotonin Oxford University Press, Oxford, UK.

    Google Scholar 

  • Gyermek J. (1966) Drugs Which Antagonize 5-Hydroxytryptamine and Related Indolealkylamines, in Handbook of Experimental Pharmacology (Eichler O and Farah A, eds., Erspamer V., sub-ed) Springer-Verlag, Berlin-Heidelberg-New York.

    Google Scholar 

  • Hall M D, El Meshkawy S., Emerit M. B., Pichat L., Hamon M., and Gozlan H. (1985). [3H] 8-Hydroxy-2-(d1-n-propylamino)tetralin binding to pre-and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem. 44, 1685–1696.

    Article  PubMed  CAS  Google Scholar 

  • Hamon M., Mallat M., Herbet A., Nelson D. L, Audinot M., Pichat L, and Glowinski J. (1981) [3H] Metergoline: A new ligand of serotonin receptors in the rat brain. J Neurochem. 36, 613–626.

    Article  PubMed  CAS  Google Scholar 

  • Hjorth S, Carlsson A, Lindberg P., Sanchez D, Wikstrom H, Arvids-son L.-E., Hacksell U., and Nillsson J. L G. (1982) 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm. 55, 169–188.

    Article  CAS  Google Scholar 

  • Hoffmann B. J., Karpa M. D, Lever J. R., and Hartig P. R. (1985) N1-methyl-2-[125I]LSD([I125]MIL)/ a preferred ligand for serotonin 5-HT2 receptors. Eur. J Pharmacol 110, 147–148

    Article  Google Scholar 

  • Hoyer D., Engel G., and Kalkman H. O. (1985a) Characterization of the 5-HT1B recognition site in rat brain. Binding studies with (−) [125I]iodocyanopmdolol. Eur. J. Pharmacol 118, 1–12.

    Article  PubMed  CAS  Google Scholar 

  • Hoyer D., Engel G., Kalkman H. O (1985b) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes. Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−) [125I]iodocyanopindolol, [3H]mesulergine and [3H]ketansenn. Eur J Pharmacol 118, 13–23.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel J., Fredericson-Over K., and Arnt J. (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram Psychopharmacology 83, 20–27.

    Article  PubMed  CAS  Google Scholar 

  • Ilien B., Schotte A, and Laduron P. M. (1982) Solubilized serotonin receptors from rat and dog brain. Selective labelling with [3H] ketan-serin. FEBS Lett 138, 311–315.

    Article  PubMed  CAS  Google Scholar 

  • Janssen P A. J. (1985) Pharmacology of potent and selective S2-sero-tonergic antagonists. J. Cardiovasc. Pharmacol 7(suppl. 7), S2–S11

    Article  PubMed  CAS  Google Scholar 

  • Kaumann A. J. (1983) A classification of heart serotonin receptors. Naunyn Schmiedebergs Arch Pharmacol, 322, R42 (166), abstract.

    Google Scholar 

  • Kaumann A. J. (1985) Two classes of myocardial 5-hydroxytryptamine receptors that are neither 5-HT1 nor 5-HT2 J Cardiovasc Pharmacol. 7(suppl. 7), S76–S78.

    Article  PubMed  CAS  Google Scholar 

  • Kohler C (1984) The distribution of serotonin binding sites in the hippocampal region of the rat brain. An autoradiographic study. Neuroscience 13, 667–680.

    Article  PubMed  CAS  Google Scholar 

  • Kuhn D. M., Wolf W A., and Youdim M B. H. (1986) Serotonin neurochemistry revisited. A new look at some old axioms. Neurochem Int 8, 141–154.

    Article  PubMed  CAS  Google Scholar 

  • Laduron P M (1984) Criteria for receptor sites in binding studies Biochem. Pharmacol 33, 833–839

    Article  PubMed  CAS  Google Scholar 

  • Laduron P M., Janssen P F. M., Gommeren W., and Leysen J E. (1982a) In vitro and in vivo binding characteristics of a new long-acting histamine-H1 antagonist astemizole Mol Pharmacol 21, 294–300

    PubMed  CAS  Google Scholar 

  • Laduron P M., Janssen P F M., and Leysen J. E (1982b) In vivo binding of [3H] ketanserin on serotonin S2-receptors in rat brain. Eur J Pharmacol. 81, 43–48.

    Article  PubMed  CAS  Google Scholar 

  • Lefkowitz R. J., Caron M. G., and Stiles G. L. (1984) Mechanisms of membrane-receptor regulation. Biochemical, physiological and clinical insights derived from studies of the adrenergic receptors. N Eng. J. Med 310, 1570–1579.

    Article  CAS  Google Scholar 

  • Leysen J. E. (1981) Serotonergic receptors in brain tissue Properties and identification of various [3H]-ligand binding sites in vitro. J. Physiol. (Paris) 77, 351–362.

    CAS  Google Scholar 

  • Leysen J E (1983) Rationale and Importance of Binding Studies in Respect to Characterization of Serotonin Receptors, in Vascular Neuroeffector Mechanisms (Bevan G. A, Fujiwara M, Maxwell R. A., Mohn K., Shibata S., and Toda N., eds.) Raven, New York

    Google Scholar 

  • Leysen J. E. (1984) Problems in in vitro receptor binding studies and identification and role of serotonin receptor-sites. Neuropharmacology 23, 247–254

    Article  PubMed  CAS  Google Scholar 

  • Leysen J. E. (1985) Characterization of Serotonin Receptor Binding Sites, in Neuropharmacology of Serotonin (ai]Green A R., ed) Oxford University Press, Oxford,UK

    Google Scholar 

  • Leysen J. E. (1988) Caractérisation des récepteurs sérotomnergiques. La Revue Médicale de Liège xLIII,Suppl 1, 12–21.

    Google Scholar 

  • Leysen J. E and Gommeren W. (1986) The drug-receptor dissociation time: New tool for drug research. Receptor binding affinity and drug-receptor dissociation profiles of serotomn-S2, dopamine-D2, histamine-H2 antagonists and opiates. Drug Dev. Res 8, 119–131.

    Article  CAS  Google Scholar 

  • Leysen J. E and Janssen P. A. J. (1988) Specificity of Ligands Used in Psychiatric Research, in Receptors and Ligands in Psychiatry and Neurology Vol. I (Sen A K. and Lee T., eds.) Cambridge University Press, Cambridge,UK.

    Google Scholar 

  • Leysen, J. E. and Laduron P M. (1977) A serotonergic component of neuroleptic receptors. Arch. Int. Pharmacodyn. Ther 230, 337–339.

    PubMed  CAS  Google Scholar 

  • Leysen J. E. and Niemegeers C. J E. (1985) Neuroleptics, in Handbook of Neurochemistry vol. 9 (Lajtha A., ed.) Plenum, New York.

    Google Scholar 

  • Leysen J. E. and Tollenaere J. P. (1982) Biochemical models for serotonin receptors. Ann. Rep Med. Chem 17, 1–10.

    Article  CAS  Google Scholar 

  • Leysen J. E., Tollenaere J. P., Koch M. H. J., and Laduron P. (1977) Differentiation of opiate and neuroleptic receptor binding in rat brain. Eur. J. Pharmacol 43, 253–267.

    Article  PubMed  CAS  Google Scholar 

  • Leysen J. E., Niemegeers C J E., Tollenaere J. P., and Laduron P. M. (1978) Serotonergic component of neuroleptic receptors. Nature 272, 168–171.

    Article  PubMed  CAS  Google Scholar 

  • Leysen J. E., Awouters F., Kennis L., Laduron P. M., Vanderberk J., and Janssen, P. A. J (1981) Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28, 1015–1022.

    Article  PubMed  CAS  Google Scholar 

  • Leysen J. E., Geerts R., Gommeren W., Verwimp M., and Van Gompel P (1982a) Regional distribution of serotonm-2 receptor binding sites in the brain and effects of neuronal lesions Arch. Int. Pharmacodyn. Ther 256, 301–305.

    PubMed  CAS  Google Scholar 

  • Leysen J. E., Niemegeers C. J. E, Van Nueten J. M, and Laduron P. M. (1982b) [3H] Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Mol. Pharmacol. 21, 301–314.

    PubMed  CAS  Google Scholar 

  • Leysen J. E, Gommeren W., and De Clerck F (1983a) Demonstration of S2-receptor binding sites on cat blood platelets using [3H] ketanserin. Eur. J. Pharmacol. 88, 125–130.

    Article  PubMed  CAS  Google Scholar 

  • Leysen J. E., Van Gompel P., Verwimp M., and Niemegeers C. J E. (1983b) Role and Localization of Serotonin2 (S2)-Receptor Binding Sites: Effects of Neuronal Lesions, in CNS Receptors. From Molecular Pharmacology to Behavior (Mandel P and De Feudis F. V., eds.) Raven, New York

    Google Scholar 

  • Leysen J E., Gommeren W., Van Gompel P., Wynants J., Janssen P. F. M., and Laduron P M. (1985) Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27, 600–611.

    PubMed  CAS  Google Scholar 

  • Leysen J. E., Van Gompel P., Gommeren W., Woestenborghs R., and Janssen P A. J. (1986) Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: Ritanserin and Setoperone. Psychopharmacology 88, 434–444.

    Article  PubMed  CAS  Google Scholar 

  • Marcinkiewicz M., Verge D, Gozlan H., Pichat L, and Hamon M. (1984) Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the brain Brain Res 291, 159–163

    Article  PubMed  CAS  Google Scholar 

  • McCall R. B. and Aghajanian, G. K. (1979) Serotonergic facilitation of facial motoneuron excitation Brain Res 169, 11–27.

    Article  PubMed  CAS  Google Scholar 

  • Middlemiss D N. (1984) 8-Hydroxy-2-(di-n-propylamino)tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site Naunyn Schmiedebergs Arch Pharmacol. 327, 18–22.

    Article  PubMed  CAS  Google Scholar 

  • Middlemiss D. N and Fozard J R. (1983) 8-Hydroxy-2-(di-n propylamino) tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90, 151–153

    Article  PubMed  CAS  Google Scholar 

  • Muller-Schweinitzer E and Engel G. (1983) Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Naunyn Schmiedebergs Arch. Pharmacol. 324, 287–292

    Article  PubMed  CAS  Google Scholar 

  • Nelson D. L. and Taylor E. W. (1985) Spiroxatrine: A selective antagonist of serotonin-lA receptors. Soc. Neurosci. Abst. part 2, 15th annual meeting, abstract 368.3.

    Google Scholar 

  • Nelson D. L., Herbet A., Adrien J, Bockaert J., and Hamon M. (1980a) Serotonin-sensitive adenylate cyclase and [3H] serotonin binding sites in the CNS of the rat II. Respective regional and subcellular distributions and ontogenetic developments. Biochem, Pharmacol 29, 2455–2463

    Article  CAS  Google Scholar 

  • Nelson D L, Herbet A., Enjalbert A., Bockaert J., and Hamon M. (1980b) Serotonin-sensitive adenylate cyclase and [3H] serotonin binding sites in the CNS of the rat. I. Kinetic parameters and pharmacological properties. Biochem Pharmacol. 29, 2445–2454

    Article  PubMed  CAS  Google Scholar 

  • Niemegeers C. J. E., Verbruggen F. J, Van Nueten J M., and Janssen P A. J. (1964) Spiroxamide (R 5188): A new compound producing morphine-like and chlorpromazine-like effects in animals. Int. J. Neuropharmacol 2, 349–354

    CAS  Google Scholar 

  • Norman A. B., Battaglia G., and Creese I (1985) [3H] WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity Mol. Pharmacol. 28, 487–494.

    PubMed  CAS  Google Scholar 

  • Ortmann R., Bischoff S., Radeke E., Buech O, and Delim-Stula A. (1982) Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn Schmiedebergs Arch. Pharmacol. 321, 265–270.

    Article  PubMed  CAS  Google Scholar 

  • Pazos A. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain I. Serotonin-1 receptors. Brain Res. 346, 205–230.

    Article  PubMed  CAS  Google Scholar 

  • Pazos A., Cortés R, and Palacios J. M. (1985a) Quantitative autoradiographic mapping of serotonin receptors in the rat brain II. Serotonin-2 receptors. Brain Res. 346, 231–249.

    Article  PubMed  CAS  Google Scholar 

  • Pazos A., Hoyer D., and Palacios J. M. (1985b) Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: Evidence for species differences in brain serotonin-2 receptors. Eur J Pharmacol. 106, 531–538.

    Article  Google Scholar 

  • Pazos A., Hoyer D., and Palacios J. M. (1985c) The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site. Eur J Pharmacol. 106, 539–546.

    Article  Google Scholar 

  • Pedigo N. W., Yamamura H. I, and Nelson D. L. (1981) Discrimination of multiple [3H] 5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain J Neurochem. 36, 220–226

    Article  PubMed  CAS  Google Scholar 

  • Peroutka S. J. (1985a) Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors Biol Psychiat. 20, 971–979.

    Article  PubMed  CAS  Google Scholar 

  • Peroutka S. J. (1985b) Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain. Brain Res 344, 167–171

    Article  PubMed  CAS  Google Scholar 

  • Peroutka S. J. (1986) Serotonin Receptors, in Neuromethods vol. 4 Receptor Binding (Boulton A. A., Baker G. B., and Hrdina P, eds.) Humana, Clifton, New Jersey.

    Google Scholar 

  • Peroutka S J and Kuhar M. J. (1984) Autoradiographic localization of 5-HT1 receptors to human and canine basilar arteries. Brain Res 310, 193–196

    Article  PubMed  CAS  Google Scholar 

  • Peroutka S J and Snyder S. H. (1979) Multiple serotonin receptors: Differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide, and [3H]-spiroperidol. Mol. Pharmacol. 16, 687–699

    PubMed  CAS  Google Scholar 

  • Peroutka S. J. and Snyder S. H. (1980) Regulation of serotomn2 (5-HT2) receptors labeled with [3H]spiropendol by chronic treatment with the antidepressant amitriptyline. J. Pharmacol. Exp. Ther 215, 582–587

    PubMed  CAS  Google Scholar 

  • Peroutka S. J. and Snyder S. H. (1981) [3H] Mianserin Differential labeling of serotonin2 and histamine1 receptors in rat brain. J. Pharmacol Exp. Ther 216, 142–148

    PubMed  CAS  Google Scholar 

  • Peroutka S. J., Lebovitz R M, and Snyder S. H. (1979) Serotonin receptor binding sites affected differentially by guanine nucleotides. Mol Pharmacol. 16, 700–708.

    PubMed  CAS  Google Scholar 

  • Peroutka S. J., Lebovitz R. M, and Snyder S. H (1981) Two distinct central serotonin receptors with different physiological functions. Science 121, 827–829.

    Article  Google Scholar 

  • Peroutka S.J., Noguchi M., Tolner D J, and Allen G S. (1983) Serotonininduced contraction of canine basilar artery Mediation by 5-HT1 receptors Brain Res 259, 327–330.

    Article  PubMed  CAS  Google Scholar 

  • Ransom R. W., Asarch K B, and Shih J. C (1986) [3H]l-[2-(4-aminophenyl)ethyl]-4-(3-tnfluoromethylphenyl)piperazine. A selective radioligand for 5-HT1A receptors in rat brain Neurochem. 46, 68–75.

    Article  CAS  Google Scholar 

  • Reyntjens A., Waelkens J., Gelders Y., Ceulemans D., and Janssen P. A. J. (1984) A novel approach for psychosomatic normalization. A placebo-controlled pilot trial of R 55 667, a potent indolamine antagonist Proc 14th Congr. Collegium Internationale Neuro-Psychopharmacologicum

    Google Scholar 

  • Richardson B. P, Engel G, Donatsch P., and Stadler P. A. (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316, 126–131.

    Article  PubMed  CAS  Google Scholar 

  • Schotte A., Maloteaux J M, and Laduron P M (1983) Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res 276, 231–235

    Article  PubMed  CAS  Google Scholar 

  • Sills M. A., Wolfe B B., and Frazer A. (1984) Determination of selective and nonselective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol. Exp Ther. 231, 480–487.

    PubMed  CAS  Google Scholar 

  • Sills M. A., Lucki I., and Frazer A. (1985) Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP. Life Sci 36, 2463–2469.

    Article  PubMed  CAS  Google Scholar 

  • Snyder S. H. and Peroutka S. J (1982) A possible role of serotonin receptors in antidepressant drug action. Pharmacopsychiatry 15, 131–134.

    Article  CAS  Google Scholar 

  • Stockmeier C A. and Kellar K J (1986) In vivo regulation of serotonin-2 receptor in rat brain Life Sci. 38, 117–127.

    Article  PubMed  CAS  Google Scholar 

  • Titeler M., Herrick K., and Lyon R. A. (1985) [3H]DOB A specific agonist radioligand for 5-HT2 serotonin receptors Eur. J. Pharmacol 117, 145–146.

    Article  PubMed  CAS  Google Scholar 

  • Tricklebank M D (1985) The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. Trends Pharmacol. Sci. 31, 403–407.

    Article  Google Scholar 

  • Vane J. R. (1957) A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol. 12, 344–349.

    CAS  Google Scholar 

  • Vanhoutte P. M, ed. (1985) Serotonin and the Cardiovascular System Raven, New York.

    Google Scholar 

  • Van Nueten J. M, Leysen J E., Vanhoutte P. M., and Janssen P A. J. (1982) Serotonergic responses in vascular and non-vascular tissues. Arch Int. Pharmacodyn Ther. 256, 331–334.

    PubMed  Google Scholar 

  • Van Nueten J M., Leysen J. E., De Clerck F, and Vanhoutte P. M. (1984) Serotonergic receptor subtypes and vascular reactivity. J. Cardiovasc Pharmacol 6(suppl. 4), S564–S574.

    Article  PubMed  Google Scholar 

  • Weiss S., Sebben M, Kemp D. E., and Bockaert J (1986) Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J Pharmacol 120, 227–230

    Article  PubMed  CAS  Google Scholar 

  • Weismann-Nanopoulos D., Mach E., Magre J., Demassey Y., and Pujol J.-F. (1985) Evidence for the localization of 5-HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int. 7, 1061–1072.

    Article  Google Scholar 

  • Wouters W., Van Dun J, Leysen J. E, and Laduron P M (1985a) Differential photoaffinity labelling of serotomn-S2 receptors and histamine-H1 receptors using 7-azidoketanserin. FEBS Lett 182, 291–296.

    Article  PubMed  CAS  Google Scholar 

  • Wouters, W., Van Dun J., Leysen J. E., and Laduron P. M. (1985b) Solubilization of rat brain serotonin-S2 receptors using CHAPS/ SALT. Eur. J. Pharmacol. 115, 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Wouters W., Janssen C. G. M, Van Dun J., Thijssen J. B A., and Laduron P M. (1986) In vitro labelling of serotonin-S2 receptors: Synthesis and binding characteristics of [3H]-aminoketanserin. J Med. Chem. 29, 1663–1668.

    Article  PubMed  CAS  Google Scholar 

  • Yagaloff K A and Hartig P. R. (1985) 125I-Lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells J. Neurosci 5, 3178–3183

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Blochemical Pharmacology, Janssen Pharmaceutica, Beerse, Belgium

    J. E. Leysen

Authors
  1. J. E. Leysen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Saskatchewan, Saskatoon, Canada

    Alan A. Boulton  & Augusto V. Juorio  & 

  2. University of Alberta, Edmonton, Canada

    Glen B. Baker

Rights and permissions

Reprints and permissions

Copyright information

© 1989 The Humana Press Inc.

About this protocol

Cite this protocol

Leysen, J.E. (1989). Use of 5-HT Receptor Agonists and Antagonists for the Characterization of Their Respective Receptor Sites. In: Boulton, A.A., Baker, G.B., Juorio, A.V. (eds) Drugs as Tools in Neurotransmitter Research. Neuromethods, vol 12. Humana Press. https://doi.org/10.1385/0-89603-122-5:299

Download citation

  • DOI: https://doi.org/10.1385/0-89603-122-5:299

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-122-7

  • Online ISBN: 978-1-59259-617-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation